Clinical Trial Update: Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 trial reports pharmacokinetic data for intranasal, intramuscular, and oral naltrexone in healthy volunteers. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-related Disorders

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders | Phase 1 | Status: COMPLETED